Cargando…

The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study

OBJECTIVES: Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. METHODS: A mathematical model, parameterised usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafer, Leigh Anne, Nsubuga, Rebecca N, Chapman, Ruth, O'Brien, Katie, Mayanja, Billy N, White, Richard G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112492/
https://www.ncbi.nlm.nih.gov/pubmed/24567521
http://dx.doi.org/10.1136/sextrans-2013-051219
_version_ 1782328186992852992
author Shafer, Leigh Anne
Nsubuga, Rebecca N
Chapman, Ruth
O'Brien, Katie
Mayanja, Billy N
White, Richard G
author_facet Shafer, Leigh Anne
Nsubuga, Rebecca N
Chapman, Ruth
O'Brien, Katie
Mayanja, Billy N
White, Richard G
author_sort Shafer, Leigh Anne
collection PubMed
description OBJECTIVES: Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. METHODS: A mathematical model, parameterised using site-specific data from Uganda and worldwide literature review, was used to examine the likely impact of ART on HIV epidemiologic trends. We varied assumptions about rates of initiating ART, and changes in sexual partner turnover rates. RESULTS: Modelling suggests that ART will reduce HIV incidence over 20 years, and increase prevalence. Even in the optimistic scenario of ART enrollment beginning after just five months of infection (in HIV stage 2), prevalence is estimated to rise from a baseline of 10.5% and 8.3% among women and men, respectively, to at least 12.1% and 10.2%, respectively. It will rise further if sexual disinhibition occurs or infectiousness while on ART is slightly higher (2% female to male, rather than 0.5%). The conditions required for ART to reduce prevalence over this period are likely too extreme to be achievable. For example, if ART enrolment begins in HIV stage 1 (within the first 5 months of infection), and if risky sexual behaviour does not increase, then 3 of our 11 top fitting results estimate a potential drop in HIV prevalence by 2025. If sexual risk taking rises, it will have a large additional impact on expected HIV prevalence. Prevalence will rise despite incidence falling, because ART extends life expectancy. CONCLUSIONS: HIV prevalence will rise. Even small increases in partner turnover rates will lead to an additional substantial increase in HIV prevalence. Policy makers are urged to continue HIV prevention activities, including promoting sex education, and to be prepared for a higher than previously suggested number of HIV infected people in need of treatment.
format Online
Article
Text
id pubmed-4112492
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41124922014-08-01 The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study Shafer, Leigh Anne Nsubuga, Rebecca N Chapman, Ruth O'Brien, Katie Mayanja, Billy N White, Richard G Sex Transm Infect Epidemiology OBJECTIVES: Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. METHODS: A mathematical model, parameterised using site-specific data from Uganda and worldwide literature review, was used to examine the likely impact of ART on HIV epidemiologic trends. We varied assumptions about rates of initiating ART, and changes in sexual partner turnover rates. RESULTS: Modelling suggests that ART will reduce HIV incidence over 20 years, and increase prevalence. Even in the optimistic scenario of ART enrollment beginning after just five months of infection (in HIV stage 2), prevalence is estimated to rise from a baseline of 10.5% and 8.3% among women and men, respectively, to at least 12.1% and 10.2%, respectively. It will rise further if sexual disinhibition occurs or infectiousness while on ART is slightly higher (2% female to male, rather than 0.5%). The conditions required for ART to reduce prevalence over this period are likely too extreme to be achievable. For example, if ART enrolment begins in HIV stage 1 (within the first 5 months of infection), and if risky sexual behaviour does not increase, then 3 of our 11 top fitting results estimate a potential drop in HIV prevalence by 2025. If sexual risk taking rises, it will have a large additional impact on expected HIV prevalence. Prevalence will rise despite incidence falling, because ART extends life expectancy. CONCLUSIONS: HIV prevalence will rise. Even small increases in partner turnover rates will lead to an additional substantial increase in HIV prevalence. Policy makers are urged to continue HIV prevention activities, including promoting sex education, and to be prepared for a higher than previously suggested number of HIV infected people in need of treatment. BMJ Publishing Group 2014-08 2014-02-24 /pmc/articles/PMC4112492/ /pubmed/24567521 http://dx.doi.org/10.1136/sextrans-2013-051219 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/
spellingShingle Epidemiology
Shafer, Leigh Anne
Nsubuga, Rebecca N
Chapman, Ruth
O'Brien, Katie
Mayanja, Billy N
White, Richard G
The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study
title The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study
title_full The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study
title_fullStr The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study
title_full_unstemmed The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study
title_short The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study
title_sort dual impact of antiretroviral therapy and sexual behaviour changes on hiv epidemiologic trends in uganda: a modelling study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112492/
https://www.ncbi.nlm.nih.gov/pubmed/24567521
http://dx.doi.org/10.1136/sextrans-2013-051219
work_keys_str_mv AT shaferleighanne thedualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT nsubugarebeccan thedualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT chapmanruth thedualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT obrienkatie thedualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT mayanjabillyn thedualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT whiterichardg thedualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT shaferleighanne dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT nsubugarebeccan dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT chapmanruth dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT obrienkatie dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT mayanjabillyn dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy
AT whiterichardg dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy